Actinium Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q3 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Actinium Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q3 2023 to Q1 2024.
  • Actinium Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending March 31, 2024 was $2.12M.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.12M Mar 31, 2024 10-Q 2024-04-26
Q3 2023 $2.27M Sep 30, 2023 10-K 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.